Select Page
FDA Clears ConforMIS, Inc.’s Knee Replacement System

FDA Clears ConforMIS, Inc.’s Knee Replacement System

The U.S. Food and Drug Administration (FDA) has granted ConforMIS Inc. 510(k) clearance for its Identity Imprint™ Knee Replacement System. Available in both posterior stabilized (PS) and cruciate retaining (CR) versions, the system expands the range of options for...
NMPA Approves PARP Inhibitor Pamiparib of BeiGene

NMPA Approves PARP Inhibitor Pamiparib of BeiGene

China’s regulatory body, the National Medical Products Administration (NMPA), has granted conditional approval to BeiGene’s PARP inhibitor pamiparib for treatment of patients advanced ovarian cancer. The approval marks the first for pamiparib and the third...